{"id":50847,"date":"2025-12-15T21:32:44","date_gmt":"2025-12-15T13:32:44","guid":{"rendered":"https:\/\/flcube.com\/?p=50847"},"modified":"2025-12-15T21:32:45","modified_gmt":"2025-12-15T13:32:45","slug":"cellular-origins-raises-40m-series-a-led-by-johnson-johnson-for-cell-therapy-manufacturing","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=50847","title":{"rendered":"Cellular Origins Raises $40M Series A Led by Johnson &amp; Johnson for Cell Therapy Manufacturing"},"content":{"rendered":"\n<p><strong>Cellular Origins<\/strong> announced the completion of an <strong>over\u2011subscribed $40\u202fmillion Series A<\/strong> financing round led by <strong>Johnson &amp; Johnson Innovation \u2013 JJDC, Inc.<\/strong> The syndicate includes <strong>Highland Europe, BGF, NYBC Ventures, and TTP Group<\/strong>. Proceeds will expand the commercial team, build global infrastructure, and advance the <strong>Constellation platform<\/strong> for automated cell therapy manufacturing.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-transaction-overview\">Transaction Overview<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Details<\/th><\/tr><\/thead><tbody><tr><td><strong>Financing Round<\/strong><\/td><td>Series A<\/td><\/tr><tr><td><strong>Amount Raised<\/strong><\/td><td>USD 40\u202fmillion<\/td><\/tr><tr><td><strong>Status<\/strong><\/td><td>Over\u2011subscribed<\/td><\/tr><tr><td><strong>Lead Investor<\/strong><\/td><td>Johnson &amp; Johnson Innovation \u2013 JJDC, Inc.<\/td><\/tr><tr><td><strong>Syndicate<\/strong><\/td><td>Highland Europe, BGF, NYBC Ventures, TTP Group<\/td><\/tr><tr><td><strong>Use of Proceeds<\/strong><\/td><td>Expand commercial team; build global infrastructure; advance platform and therapy development<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-technology-platform\">Technology Platform<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Platform<\/th><th>Constellation<\/th><\/tr><\/thead><tbody><tr><td><strong>Components<\/strong><\/td><td>Mobile robotics, automated sterile welding, integrated bioprocess instruments<\/td><\/tr><tr><td><strong>Key Benefit<\/strong><\/td><td>Eliminates need for therapy redevelopment; provides dependable clinical\u2011to\u2011commercial manufacturing route<\/td><\/tr><tr><td><strong>Application<\/strong><\/td><td>Cell therapy production scaling<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-strategic-implications\">Strategic Implications<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>For Cellular Origins:<\/strong> Validates its automated manufacturing platform with a premier corporate investor; provides runway for commercial\u2011scale deployment and global expansion.<\/li>\n\n\n\n<li><strong>For Johnson &amp; Johnson:<\/strong> Strategic entry into cell therapy infrastructure; JJDC investment aligns with J&amp;J\u2019s broader cell and gene therapy ambitions.<\/li>\n\n\n\n<li><strong>For Market:<\/strong> Addresses critical <strong>manufacturing bottleneck<\/strong> limiting cell therapy adoption; automated platforms are essential for sector\u2011wide scalability.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-market-context\">Market Context<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Metric<\/th><th>Value<\/th><\/tr><\/thead><tbody><tr><td><strong>Global Cell Therapy Market<\/strong><\/td><td>$10\u202fbillion (2025)<\/td><\/tr><tr><td><strong>Projected 2030 Market<\/strong><\/td><td>$30\u202fbillion<\/td><\/tr><tr><td><strong>Manufacturing Cost<\/strong><\/td><td>40\u201160% of total therapy cost<\/td><\/tr><tr><td><strong>Automation Need<\/strong><\/td><td>Critical for scaling production and reducing cost\u2011of\u2011goods<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward\u2011looking statements regarding Cellular Origins\u2019 platform advancement, market penetration, and technology development. Actual results may differ due to technical risks, competitive responses, or market adoption rates.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Cellular Origins announced the completion of an over\u2011subscribed $40\u202fmillion Series A financing round led by&#8230;<\/p>\n","protected":false},"author":1,"featured_media":50851,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[77,4504,20],"class_list":["post-50847","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-cell-therapy","tag-cellular-origins","tag-finance"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Cellular Origins Raises $40M Series A Led by Johnson &amp; Johnson for Cell Therapy Manufacturing - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Cellular Origins announced the completion of an over\u2011subscribed $40\u202fmillion Series A financing round led by Johnson &amp; Johnson Innovation \u2013 JJDC, Inc. The syndicate includes Highland Europe, BGF, NYBC Ventures, and TTP Group. Proceeds will expand the commercial team, build global infrastructure, and advance the Constellation platform for automated cell therapy manufacturing.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=50847\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cellular Origins Raises $40M Series A Led by Johnson &amp; Johnson for Cell Therapy Manufacturing\" \/>\n<meta property=\"og:description\" content=\"Cellular Origins announced the completion of an over\u2011subscribed $40\u202fmillion Series A financing round led by Johnson &amp; Johnson Innovation \u2013 JJDC, Inc. The syndicate includes Highland Europe, BGF, NYBC Ventures, and TTP Group. Proceeds will expand the commercial team, build global infrastructure, and advance the Constellation platform for automated cell therapy manufacturing.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=50847\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-15T13:32:44+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-15T13:32:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/12\/1509.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=50847#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=50847\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Cellular Origins Raises $40M Series A Led by Johnson &amp; Johnson for Cell Therapy Manufacturing\",\"datePublished\":\"2025-12-15T13:32:44+00:00\",\"dateModified\":\"2025-12-15T13:32:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=50847\"},\"wordCount\":276,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=50847#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/1509.webp\",\"keywords\":[\"Cell-therapy\",\"Cellular Origins\",\"Finance\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=50847#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=50847\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=50847\",\"name\":\"Cellular Origins Raises $40M Series A Led by Johnson &amp; Johnson for Cell Therapy Manufacturing - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=50847#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=50847#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/1509.webp\",\"datePublished\":\"2025-12-15T13:32:44+00:00\",\"dateModified\":\"2025-12-15T13:32:45+00:00\",\"description\":\"Cellular Origins announced the completion of an over\u2011subscribed $40\u202fmillion Series A financing round led by Johnson & Johnson Innovation \u2013 JJDC, Inc. The syndicate includes Highland Europe, BGF, NYBC Ventures, and TTP Group. Proceeds will expand the commercial team, build global infrastructure, and advance the Constellation platform for automated cell therapy manufacturing.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=50847#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=50847\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=50847#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/1509.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/1509.webp\",\"width\":1080,\"height\":608,\"caption\":\"Cellular Origins Raises $40M Series A Led by Johnson & Johnson for Cell Therapy Manufacturing\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=50847#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cellular Origins Raises $40M Series A Led by Johnson &amp; Johnson for Cell Therapy Manufacturing\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Cellular Origins Raises $40M Series A Led by Johnson &amp; Johnson for Cell Therapy Manufacturing - Insight, China&#039;s Pharmaceutical Industry","description":"Cellular Origins announced the completion of an over\u2011subscribed $40\u202fmillion Series A financing round led by Johnson & Johnson Innovation \u2013 JJDC, Inc. The syndicate includes Highland Europe, BGF, NYBC Ventures, and TTP Group. Proceeds will expand the commercial team, build global infrastructure, and advance the Constellation platform for automated cell therapy manufacturing.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=50847","og_locale":"en_US","og_type":"article","og_title":"Cellular Origins Raises $40M Series A Led by Johnson &amp; Johnson for Cell Therapy Manufacturing","og_description":"Cellular Origins announced the completion of an over\u2011subscribed $40\u202fmillion Series A financing round led by Johnson & Johnson Innovation \u2013 JJDC, Inc. The syndicate includes Highland Europe, BGF, NYBC Ventures, and TTP Group. Proceeds will expand the commercial team, build global infrastructure, and advance the Constellation platform for automated cell therapy manufacturing.","og_url":"https:\/\/flcube.com\/?p=50847","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-12-15T13:32:44+00:00","article_modified_time":"2025-12-15T13:32:45+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/12\/1509.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=50847#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=50847"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Cellular Origins Raises $40M Series A Led by Johnson &amp; Johnson for Cell Therapy Manufacturing","datePublished":"2025-12-15T13:32:44+00:00","dateModified":"2025-12-15T13:32:45+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=50847"},"wordCount":276,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=50847#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/12\/1509.webp","keywords":["Cell-therapy","Cellular Origins","Finance"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=50847#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=50847","url":"https:\/\/flcube.com\/?p=50847","name":"Cellular Origins Raises $40M Series A Led by Johnson &amp; Johnson for Cell Therapy Manufacturing - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=50847#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=50847#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/12\/1509.webp","datePublished":"2025-12-15T13:32:44+00:00","dateModified":"2025-12-15T13:32:45+00:00","description":"Cellular Origins announced the completion of an over\u2011subscribed $40\u202fmillion Series A financing round led by Johnson & Johnson Innovation \u2013 JJDC, Inc. The syndicate includes Highland Europe, BGF, NYBC Ventures, and TTP Group. Proceeds will expand the commercial team, build global infrastructure, and advance the Constellation platform for automated cell therapy manufacturing.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=50847#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=50847"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=50847#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/12\/1509.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/12\/1509.webp","width":1080,"height":608,"caption":"Cellular Origins Raises $40M Series A Led by Johnson & Johnson for Cell Therapy Manufacturing"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=50847#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Cellular Origins Raises $40M Series A Led by Johnson &amp; Johnson for Cell Therapy Manufacturing"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/12\/1509.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/50847","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=50847"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/50847\/revisions"}],"predecessor-version":[{"id":50852,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/50847\/revisions\/50852"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/50851"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=50847"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=50847"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=50847"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}